| Radial versus femoral access in patients with acute coronary syndromes undergoing invasive management: a randomised multicentre trial M Valgimigli, A Gagnor, P Calabró, E Frigoli, S Leonardi, T Zaro, ... The Lancet 385 (9986), 2465-2476, 2015 | 1489 | 2015 |
| Bivalirudin or unfractionated heparin in acute coronary syndromes M Valgimigli, E Frigoli, S Leonardi, M Rothenbühler, A Gagnor, P Calabrò, ... New England Journal of Medicine 373 (11), 997-1009, 2015 | 424 | 2015 |
| Comparison of angioplasty with infusion of tirofiban or abciximab and with implantation of sirolimus-eluting or uncoated stents for acute myocardial infarction: the … M Valgimigli, G Campo, G Percoco, L Bolognese, C Vassanelli, ... Jama 299 (15), 1788-1799, 2008 | 363 | 2008 |
| Zotarolimus-eluting versus bare-metal stents in uncertain drug-eluting stent candidates M Valgimigli, A Patialiakas, A Thury, E McFadden, S Colangelo, G Campo, ... Journal of the American College of Cardiology 65 (8), 805-815, 2015 | 320 | 2015 |
| Radial versus femoral access and bivalirudin versus unfractionated heparin in invasively managed patients with acute coronary syndrome (MATRIX): final 1-year results of a … M Valgimigli, E Frigoli, S Leonardi, P Vranckx, M Rothenbühler, M Tebaldi, ... The Lancet 392 (10150), 835-848, 2018 | 301 | 2018 |
| Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY … KK Ray, HM Colhoun, M Szarek, M Baccara-Dinet, DL Bhatt, VA Bittner, ... The lancet Diabetes & endocrinology 7 (8), 618-628, 2019 | 293 | 2019 |
| Upward shift of the lower range of coronary flow autoregulation in hypertensive patients with hypertrophy of the left ventricle. A Polese, N De Cesare, P Montorsi, F Fabbiocchi, M Guazzi, A Loaldi, ... Circulation 83 (3), 845-853, 1991 | 252 | 1991 |
| Intensifying platelet inhibition with tirofiban in poor responders to aspirin, clopidogrel, or both agents undergoing elective coronary intervention: results from the double … M Valgimigli, G Campo, N de Cesare, E Meliga, P Vranckx, A Furgieri, ... Circulation 119 (25), 3215-3222, 2009 | 232 | 2009 |
| Prediction of 1-year clinical outcomes using the SYNTAX score in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary … S Garg, G Sarno, PW Serruys, AE Rodriguez, L Bolognese, M Anselmi, ... JACC: Cardiovascular Interventions 4 (1), 66-75, 2011 | 227 | 2011 |
| Cyclosporine A in reperfused myocardial infarction: the multicenter, controlled, open-label CYCLE trial F Ottani, R Latini, L Staszewsky, L La Vecchia, N Locuratolo, M Sicuro, ... Journal of the American College of Cardiology 67 (4), 365-374, 2016 | 218 | 2016 |
| Comparison of nifedipine, propranolol and isosorbide dinitrate on angiographic progression and regression of coronary arterial narrowings in angina pectoris A Loaldi, A Polese, P Montorsi, N De Cesare, F Fabbiocchi, P Ravagnani, ... The American journal of cardiology 64 (8), 433-439, 1989 | 188 | 1989 |
| Is bare-metal stent implantation still justifiable in high bleeding risk patients undergoing percutaneous coronary intervention? A pre-specified analysis from the ZEUS trial S Ariotti, M Adamo, F Costa, A Patialiakas, C Briguori, A Thury, ... JACC: Cardiovascular Interventions 9 (5), 426-436, 2016 | 178 | 2016 |
| Long-term clinical outcome based on aspirin and clopidogrel responsiveness status after elective percutaneous coronary intervention: a 3T/2R (tailoring treatment with tirofiban … G Campo, L Fileti, N de Cesare, E Meliga, A Furgieri, F Russo, ... Journal of the American College of Cardiology 56 (18), 1447-1455, 2010 | 167 | 2010 |
| Emergency percutaneous coronary intervention in patients with ST-elevation myocardial infarction complicated by out-of-hospital cardiac arrest: early and medium-term outcome C Lettieri, S Savonitto, S De Servi, G Guagliumi, G Belli, A Repetto, ... American heart journal 157 (3), 569-575. e1, 2009 | 153 | 2009 |
| Afterload reduction: a comparison of captopril and nifedipine in dilated cardiomyopathy. PG Agostoni, N De Cesare, E Doria, A Polese, G Tamborini, MD Guazzi Heart 55 (4), 391-399, 1986 | 142 | 1986 |
| Calcium-channel blockade with nifedipine and angiotensin converting-enzyme inhibition with captopril in the therapy of patients with severe primary hypertension. MD Guazzi, N De Cesare, C Galli, A Salvioni, C Tramontana, G Tamborini, ... Circulation 70 (2), 279-284, 1984 | 136 | 1984 |
| Relation of stenosis morphology and clinical presentation to the procedural results of directional coronary atherectomy. SG Ellis, NB De Cesare, CA Pinkerton, P Whitlow, SB King 3rd, ... Circulation 84 (2), 644-653, 1991 | 119 | 1991 |
| Timing of Oral P2Y12 Inhibitor Administration in Patients With Non-ST-Segment Elevation Acute Coronary Syndrome G Tarantini, M Mojoli, F Varbella, R Caporale, S Rigattieri, G Ando, ... Journal of the American College of Cardiology 76 (21), 2450-2459, 2020 | 97 | 2020 |
| Coronary adrenergic hyperreactivity in patients with syndrome X and abnormal electrocardiogram at rest P Montorsi, F Fabbiocchi, A Loaldi, L Annoni, A Polese, N De Cesare, ... The American journal of cardiology 68 (17), 1698-1703, 1991 | 94 | 1991 |
| MATRIX Investigators. Radial versus femoral access in patients with acute coronary syndromes undergoing invasive management: a randomised multicentre trial M Valgimigli, A Gagnor, P Calabró, E Frigoli, S Leonardi, T Zaro, ... Lancet 385 (9986), 2465-2476, 2015 | 81 | 2015 |
